PL2701693T3 - Tapentadol do profilaktyki i leczenia depresji i lęku - Google Patents

Tapentadol do profilaktyki i leczenia depresji i lęku

Info

Publication number
PL2701693T3
PL2701693T3 PL12720794T PL12720794T PL2701693T3 PL 2701693 T3 PL2701693 T3 PL 2701693T3 PL 12720794 T PL12720794 T PL 12720794T PL 12720794 T PL12720794 T PL 12720794T PL 2701693 T3 PL2701693 T3 PL 2701693T3
Authority
PL
Poland
Prior art keywords
tapentadol
anxiety
preventing
treating depression
depression
Prior art date
Application number
PL12720794T
Other languages
English (en)
Inventor
Ilona Steigerwald
Ulrich Jahnel
Thomas Tzschentke
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of PL2701693T3 publication Critical patent/PL2701693T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL12720794T 2011-04-29 2012-04-27 Tapentadol do profilaktyki i leczenia depresji i lęku PL2701693T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11003508 2011-04-29
EP12720794.2A EP2701693B1 (en) 2011-04-29 2012-04-27 Tapentadol for preventing and treating depression and anxiety
PCT/EP2012/001819 WO2012146383A1 (en) 2011-04-29 2012-04-27 Tapentadol for preventing and treating depression and anxiety

Publications (1)

Publication Number Publication Date
PL2701693T3 true PL2701693T3 (pl) 2018-01-31

Family

ID=44260882

Family Applications (2)

Application Number Title Priority Date Filing Date
PL17185830T PL3272343T3 (pl) 2011-04-29 2012-04-27 Tapentadol w prewencji i leczeniu depresji i lęku
PL12720794T PL2701693T3 (pl) 2011-04-29 2012-04-27 Tapentadol do profilaktyki i leczenia depresji i lęku

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL17185830T PL3272343T3 (pl) 2011-04-29 2012-04-27 Tapentadol w prewencji i leczeniu depresji i lęku

Country Status (15)

Country Link
US (3) US20120277319A1 (pl)
EP (3) EP2701693B1 (pl)
JP (3) JP6014655B2 (pl)
CY (2) CY1119586T1 (pl)
DK (2) DK2701693T3 (pl)
ES (2) ES2646363T3 (pl)
HR (2) HRP20171570T1 (pl)
HU (2) HUE049308T2 (pl)
LT (2) LT3272343T (pl)
NO (1) NO2701693T3 (pl)
PL (2) PL3272343T3 (pl)
PT (2) PT2701693T (pl)
RS (2) RS56523B1 (pl)
SI (2) SI3272343T1 (pl)
WO (1) WO2012146383A1 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
BR112012001466A2 (pt) 2009-07-22 2020-08-11 Grünenthal GmbH forma de dosagem resistente à falsificação para opioides sensíveis à oxidação, seu processo de fabricação, e embalagem
BR112014002022A2 (pt) 2011-07-29 2017-02-21 Gruenenthal Gmbh comprimido resistente à violação proporcionando liberação de fármaco imediata
JP6063462B2 (ja) 2011-07-29 2017-01-18 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 即時薬剤放出を提供するタンパーレジスタント錠剤
US10813630B2 (en) 2011-08-09 2020-10-27 Corquest Medical, Inc. Closure system for atrial wall
US10307167B2 (en) 2012-12-14 2019-06-04 Corquest Medical, Inc. Assembly and method for left atrial appendage occlusion
US10314594B2 (en) 2012-12-14 2019-06-11 Corquest Medical, Inc. Assembly and method for left atrial appendage occlusion
US20140142689A1 (en) 2012-11-21 2014-05-22 Didier De Canniere Device and method of treating heart valve malfunction
AU2014289187B2 (en) 2013-07-12 2019-07-11 Grunenthal Gmbh Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
EP2845625A1 (en) * 2013-09-04 2015-03-11 Grünenthal GmbH Tapentadol for use in the treatment of fibromyalgia and chronic fatigue syndrome
HK1224189A1 (zh) 2013-11-26 2017-08-18 Grünenthal GmbH 通过低温研磨制备粉状药物组合物
US9566443B2 (en) 2013-11-26 2017-02-14 Corquest Medical, Inc. System for treating heart valve malfunction including mitral regurgitation
US10842626B2 (en) 2014-12-09 2020-11-24 Didier De Canniere Intracardiac device to correct mitral regurgitation
CA2986891C (en) * 2015-05-26 2022-01-04 Technophage, Investigacao E Desenvolvimento Em Biotecnologia, Sa Compositions for use in treating parkinson's disease and related disorders
CA2998259A1 (en) 2015-09-10 2017-03-16 Grunenthal Gmbh Protecting oral overdose with abuse deterrent immediate release formulations
US10292948B2 (en) * 2017-01-11 2019-05-21 Torrent Pharmaceuticals Limited Tapentadol nasal composition
EP3630074B1 (en) * 2017-05-29 2023-10-25 Grünenthal GmbH Multiparticulate oral dosage form providing prolonged release of tapentadol

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783337A (en) 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4765989A (en) 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US4612008A (en) 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
DE4426245A1 (de) 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
PE20030527A1 (es) 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
JP5276982B2 (ja) 2005-08-26 2013-08-28 ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ オキシトシンの投与による頭痛の処置のための方法
WO2007088473A2 (en) 2006-02-03 2007-08-09 Neurocure Ltd Treatment and prevention of depression with pain, depression secondary to pain, and of neuropathic pain
CN102675136B (zh) 2006-04-28 2016-01-20 格吕伦塔尔有限公司 包含3-(3-二甲基氨基-1-乙基-2-甲基-丙基)-苯酚和nsaid的药物组合物
DE102007012165A1 (de) 2007-03-12 2008-09-18 Grünenthal GmbH Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie des Neuropathieschmerzes
EP1985292A1 (en) 2007-04-23 2008-10-29 Grünenthal GmbH Titration of tapentadol
MX2010005680A (es) 2007-11-23 2010-12-21 Protect Pharmaceutical Corp Composiciones de tapentadol.
EP2254577A1 (en) 2007-12-26 2010-12-01 Eisai R&D Management Co., Ltd. Ampa receptor antagonists for epilepsy, mental disorders or deficits in sensory organ
WO2009094577A2 (en) 2008-01-25 2009-07-30 Xenoport, Inc. Mesophasic forms of (3s)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
WO2009094563A2 (en) 2008-01-25 2009-07-30 Xenoport, Inc. Crystalline form of calcium-salts of (3s)-aminomethyl-b-methyl-hexanoic acids and methods of use
WO2010100477A2 (en) 2009-03-03 2010-09-10 Shire Llc Amino acid and peptide carbamate prodrugs of tapentadol and uses thereof
CA2757757C (en) 2009-04-30 2017-10-24 Ulrich Jahnel Use of 1-phenyl-3-dimethylaminopropane compounds for treating rheumatoid pain
FR2970261B1 (fr) 2011-01-10 2013-05-03 IFP Energies Nouvelles Procede d'hydrotraitement de charges lourdes d'hydrocarbures avec des reacteurs permutables incluant au moins une etape de permutation progressive
SI2694049T1 (sl) 2011-04-05 2019-01-31 Gruenenthal Gmbh Tapentadol za preprečevanje razvoja kronične bolečine

Also Published As

Publication number Publication date
WO2012146383A1 (en) 2012-11-01
HRP20171570T1 (hr) 2017-11-17
US20120277319A1 (en) 2012-11-01
NO2701693T3 (pl) 2018-01-20
EP3272343A1 (en) 2018-01-24
HRP20200600T1 (hr) 2020-10-16
EP3656380A1 (en) 2020-05-27
HUE034003T2 (en) 2018-02-28
CY1123051T1 (el) 2021-10-29
ES2646363T3 (es) 2017-12-13
JP2018021053A (ja) 2018-02-08
EP2701693B1 (en) 2017-08-23
JP2014516935A (ja) 2014-07-17
LT3272343T (lt) 2020-05-11
HUE049308T2 (hu) 2020-09-28
PT3272343T (pt) 2020-04-23
PT2701693T (pt) 2017-11-16
JP6014655B2 (ja) 2016-10-25
ES2788548T3 (es) 2020-10-21
US20150018426A1 (en) 2015-01-15
JP6445637B2 (ja) 2018-12-26
CY1119586T1 (el) 2018-03-07
SI2701693T1 (sl) 2017-11-30
RS60152B1 (sr) 2020-05-29
PL3272343T3 (pl) 2020-07-27
EP3272343B1 (en) 2020-02-12
RS56523B1 (sr) 2018-02-28
SI3272343T1 (sl) 2020-06-30
DK2701693T3 (da) 2017-11-13
US20170196822A1 (en) 2017-07-13
LT2701693T (lt) 2017-11-10
JP2017031182A (ja) 2017-02-09
EP2701693A1 (en) 2014-03-05
US9980927B2 (en) 2018-05-29
DK3272343T3 (da) 2020-04-27

Similar Documents

Publication Publication Date Title
LT3272343T (lt) Tapentadolis, skirtas depresijos ir nerimo prevencijai ir gydymui
ZA201401526B (en) Method and formulation for inhalation
EP2768443A4 (en) METHODS AND DEVICES FOR TREATING HYPERTENSION
EP2615533A4 (en) INTERACTION PROCEDURE AND INTERACTION DEVICE
PL2696754T3 (pl) Urządzenie i sposób pomiaru stresu
IL229844B (en) Anti-psgl-1 antibodies and their use
PT2663864T (pt) Método de avaliação de imunodiversidade e seu uso
GB201122195D0 (en) Composition and method
GB201408236D0 (en) Composition and method
GB201110783D0 (en) Methods and uses
EP2757849A4 (en) METHOD AND DEVICE FOR MULTI-CARRIER PLANNING
EP2755363A4 (en) METHOD AND DEVICE FOR FAST DATA DISTRIBUTION
GB201116774D0 (en) Uses and methods
GB201101862D0 (en) Method and device
PT2697875T (pt) Dispositivo antiestático e método operativo associado
PL2683245T3 (pl) Sposoby i kompozycje do leczenia depresji przy użyciu cyklobenzapryny
PL2667710T3 (pl) Kompozycja owadobójcza i związane z nią sposoby
GB201106433D0 (en) Composition and method
EP2721788A4 (en) METHOD AND ARRANGEMENT FOR SENDING QUESTIONS
GB2489303B (en) Preserved-traveltime smoothing method and device
PL2663585T3 (pl) Związki oligomocznika oraz sposób ich wytwarzania i ich zastosowanie
GB2492973B (en) Authentication system and method therefor
GB201108490D0 (en) Methods and uses
PL2508592T3 (pl) Sposób mieszania i urządzenie do realizacji wspomnianego procesu mieszania
GB201109991D0 (en) Process and device